Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

0.6890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn't be applying for a crucial authorization. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Shares Are Getting Hammered Today
Ocugen Inc (NASDAQ: OCGN) shares were trading 22.18% lower off the open Thursday at $7.24 after the company announced it will pursue a biologics license application path for... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Verona Pharma (NASDAQ:VRNA) stock moved upwards by 15.2% to $7.5 during Thursday's pre-market session. The market value of their outstanding shares is at $434.... 
Via Benzinga
Could Ocugen Be a Millionaire-Maker Stock?
The ability of this biotech to sell its coronavirus vaccine in a timely manner has caused a lot of headaches for investors. 
Via The Motley Fool
Exposures COVID-19
3 Tips for COVID Vaccine Stock Investing Right Now
Coronavirus vaccine investing is far from over. 
Via The Motley Fool
Topics Cannabis
Exposures COVID-19 Cannabis
Why Ocugen's Stock Is Trading Higher Today
Ocugen (NASDAQ:OCGN) shares are trading higher a... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
Via Benzinga
Why Ocugen Stock Fell 31.1% in May
The biopharmaceutical company, known for its portfolio of eye therapy drugs, has a COVID-19 vaccine in the works. 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Nymox Pharmaceutical (NASDAQ:NYMX... 
Via Benzinga
OCGN stock: The Big COVAXIN News Boosting Ocugen Today
Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada. 
Via InvestorPlace
When It Comes to Ocugen Stock I’m Damned If I Do or Don’t
After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits? 
Via InvestorPlace
This New Vaccine Market Could Be Bigger for Ocugen Than the U.S.
Ocugen is casting a wider net. 
Via The Motley Fool
Exposures COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
It seems as though INO stock will have a tough time getting and staying in double digits 
Via InvestorPlace
The Same Problems Persist for Ocugen in Marketing Covaxin
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward in the long term. 
Via InvestorPlace
Exposures COVID-19
28 Stocks Moving in Thursday's Pre-Market Session
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14... 
Via Benzinga
Did the FDA Slam the Door on Ocugen's Chances of Winning Authorization for Covaxin?
The agency's revised emergency-authorization guidance for COVID-19 vaccines appears to present a significant hurdle for Ocugen. 
Via The Motley Fool
Exposures COVID-19 Product Safety
FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock
The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short. 
Via InvestorPlace
Exposures COVID-19 Product Safety
10 Current And Former Penny Stocks With High Short Interest As BB & GME Stock Attract More Reddit Interest
Reddit stocks have surged thanks to big moves in BB and GME. With short interest as the focus, here are a few penny stocks to watch right now. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tilray (NASDAQ:TLRY) shares incre... 
Via Benzinga
How Risky Is Ocugen?
An EUA for its coronavirus vaccine candidate may be on the horizon. 
Via The Motley Fool
Exposures COVID-19
Ocugen Stock Is a Speculative Covid-19 Vaccine Bet
OCGN stock is a speculative bet. An approval of Covaxin by the FDA would boost OCGN stock. However, the firm's revenue potential is limited. 
Via InvestorPlace
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
Why Ocugen Stock Is Moving Today
Ocugen Inc (NASDAQ: OCGN) shares gained 13.71% to $8.71 Thursday after the company announced it's on track to submit its Emergency Use Authorization application to the... 
Via Benzinga
Ocugen Stock Will Probably Drop Below $1
Ocugen will only make money from sales of its vaccine in the United States, but by the time that's possible, it'll be too late. 
Via InvestorPlace
Exposures COVID-19
Take Your Ocugen Stock Profits and Run If You Haven’t Already
Though OCGN stock provided lifechanging profitability to speculators, these Cinderella stories usually come to a devastating end. 
Via InvestorPlace
Exposures COVID-19
OCGN Stock: The Big FDA News Lifting Ocugen Shares Today
OCGN stock is on the move today as biopharma Ocugen confirms its intent to submit an EUA for Covaxin in June 2021. 
Via InvestorPlace
Exposures COVID-19 Product Safety
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 82% to $3.24 in pre-market trading after the company announced plans to acquire a Alabama refinery and related logistics assets.... 
Via Benzinga
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
Via Benzinga
Exposures COVID-19
2 Reasons to Avoid Ocugen Stock -- and 1 Reason to Considering Buying It
The company has a path to success in the COVID-19 vaccine market, but it might be more of an uphill climb than some investors realize. 
Via The Motley Fool
Exposures COVID-19
Here's What Is Going On With Ocugen (OCGN) Stock
Shares of Ocugen Inc. (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, fell 3.7% in Wednesday’s regular trading session. What... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.